DESSIE VETTER: Open Payments
NPI 1891131116 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 24 payments from 12 companies in 2025. Trend: 2023 $374 · 2024 $340 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $133 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| CooperSurgical, Inc. | 1 | $75 |
| Biogen, Inc. | 3 | $70 |
| MILLICENT US INC | 2 | $40 |
| Organon LLC | 2 | $31 |
| Hologic Sales and Service, LLC | 1 | $29 |
| Dexcom, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $16 |
Products named: Veozah, Paragard T 380A, ZURZUVAE, Mirena, NEXPLANON, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Lynkuet, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
